Overview
Keheala is a mobile health company that improves healthcare access and treatment outcomes for patients. By empowering patients with information, motivation and support, Keheala delivers the tools needed to overcome the non-medical drivers of disease that exist away from health facilities. Healthcare agencies are provided remote-monitoring capabilities and vital analytics to combat epidemics in resource-constrained environments.
Keheala has been covered in the New York Times and World Economic Forum.
How it works
Patients are enrolled in Keheala at a health care facility via their feature phone. They receive text messages to verify that they have to take their medication. If the patient does not respond, a trained Keheala team reaches out for support remotely.
Scoring
Keheala has been scored below according to it’s ability to serve the TB market for low- and middle-income countries (LMICs) along Fit for Purpose and Technical Specifications metrics. Note that higher scores equate to a greater ability to serve the market. For example, if a product scores well in the Provider Burden subcategory, that means that the burden for the provider is low.
For full descriptions of the sub-categories, see the 2021 DAT Market Landscape.
Fit for Purpose
Technical Specifications
Advantages
- Can be used from any feature phone or smartphone
- No device to set up or maintain
- Program is well-established for TB and in LMICs
Disadvantages
- Adherence activity is entirely self-reported
- Requires consistent electricity access
Access
For more information on Keheala, please visit the Keheala website.